| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2578946 | Thérapie | 2013 | 5 Pages |
Abstract
Concerning the evaluation procedure: the time to market access must not be lengthened; while the possibility of regular meetings between the industry and the HAS is recommended to avoid methodological divergences. A transitory period should allow the implementation of the entire evaluation procedure which must also take into account the specificities of health products registered before the 3 October 2013.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, participants of round table N°6 of Giens Workshops XXVIII: participants of round table N°6 of Giens Workshops XXVIII:, Véronique Ameye, Pierre Angot, Antoine Audry, Laurent Becquemont, Thomas Borel,